Profil
Mr. Lars Ole Öhman is a Chairman at Kubera Pharmaceuticals AB, a Chairman at Lipigon Pharmaceuticals AB and a Chairman at Betulaceae Pharmaceuticals AB. He is on the Board of Directors at Cordator Life Science AB, Immunscape AB and Kubator Therapeutics AB. Mr. Öhman was previously employed as a Vice President-Business Development by Karo Healthcare AB. He received his undergraduate degree from Royal Institute of Technology and an MBA from Stockholm School of Economics.
Postes actifs de Lars Ole Öhman
| Sociétés | Poste | Début |
|---|---|---|
| LIPIGON PHARMACEUTICALS AB | Président | 01/09/2026 |
Kubera Pharmaceuticals AB | Président | 01/07/2012 |
Betulaceae Pharmaceuticals AB | Président | - |
Kubator Therapeutics AB | Directeur/Membre du Conseil | 01/07/2012 |
Cordator Life Science AB | Directeur/Membre du Conseil | 01/01/2018 |
Immunscape AB | Directeur/Membre du Conseil | 01/07/2016 |
Anciens postes connus de Lars Ole Öhman
| Sociétés | Poste | Fin |
|---|---|---|
| KARO PHARMA AB (PUBL) | Corporate Officer/Principal | - |
Formation de Lars Ole Öhman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Karo Healthcare AB
Karo Healthcare AB Household/Personal CareConsumer Non-Durables Manufactures skincare products, cosmetics, supplements and digestive pharmaceuticals | Consumer Non-Durables |
Stockholm School of Economics
Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Royal Institute of Technology
Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lipigon Pharmaceuticals AB
Lipigon Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops drugs aiming at treating dyslipidemia patients | Health Technology |
Kubator Therapeutics AB | |
Betulaceae Pharmaceuticals AB | |
Kubera Pharmaceuticals AB | |
Cordator Life Science AB | |
Immunscape AB |
















